Infinity Pharmaceuticals | INFI - Процентные расходы





Процентные расходы Изменить Дата
AbbVie USD 645M 69M 2026-03
Amgen USD 657M 4M 2026-03
AstraZeneca USD 484M 181M 2025-12
Bristol-Myers Squibb USD 411M 21M 2026-03
Cipla INR 131.3M 9M 2026-03
Compugen USD 954K 116K 2025-09
CSL USD 215M 111M 2025-12
Eisai JPY 1.55B 117M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Gilead Sciences USD 240M 15M 2026-03
GlaxoSmithKline GBP 167M 21M 2026-03
Grifols EUR 156.07M 31.46M 2025-09
Incyte USD 569K 13K 2026-03
Infinity Pharmaceuticals USD 45K 0 2023-06
Ionis Pharmaceuticals USD 17M 1000K 2026-03
J&J USD 43M 25M 2026-03
Novartis USD 343M 39M 2026-03
Pfizer USD 671M 40M 2026-03
Plus Therapeutics USD 62K 25K 2023-12
Roche Holding CHF 304M 7.5M 2025-06
TG Therapeutics USD 7.67M 1.13M 2026-03